Clicky

Yunkang Group Ltd(2325)

Description: Yunkang Group Limited operates as a medical operation service provider in China. It offers diagnostic outsourcing and diagnostic testing services, such as genetic reproduction tests and screening tests, COVID-19 and non-COVID-19 tests, diagnostic testing, pathology tests, personalized diagnostic testing, medical report consultation, hospital referral, and health management services; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papillomavirus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; and routine diagnostic tests for chronic kidney disease, blood disease, autoimmune disease, and endocrine metabolism disease. The company also provides technical support for the set-up and daily operation of the on-site diagnostic centers, which include setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, provision of equipment, smart internet of things, and logistics assistance; and medical consultation services. It offers its services through independent clinical laboratories and on-site diagnostic centers. As of December 31, 2021, the company had six laboratories located in Guangzhou, Chengdu, Shanghai, Hefei, Kunming, and Nanchang. It serves hospitals, community health clinics and other medical institutions, financial institutions, and insurance companies. Yunkang Group Limited was founded in 2008 and is based in Guangzhou, China.


Keywords: Insurance Infectious Diseases Autoimmune Disease Diagnostic Tests Chronic Kidney Disease Tuberculosis Medical Diagnosis Health Management Services Medical Consultation Services Diagnostic Testing Services Smart Internet

Home Page: www.yunkanghealth.com

No. 6 Lizhishan Road
Guangzhou,
China
Phone: 86 20 3210 6666


Officers

Name Title
Mr. Yong Zhang Chairman & CEO
Mr. Yingjia Lin CFO & Joint Company Sec.
Mr. Xubo Wang Exec. VP
Ms. Lok Yee Chan A.C.I.S., A.C.S. Joint Company Sec.

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 15.015
Trailing PE: 19.3882
Price-to-Book MRQ: 3.6187
Price-to-Sales TTM: 4.3054
IPO Date:
Fiscal Year End: December
Full Time Employees: 2476
Back to stocks